Skip to content
stoqly
en · USD

Appearance

Language

Currency

Popular

All currencies

Data is in US dollars, converted at the exchange rate of Oct 28, 2026.

Sign in

Howard G. Welgus

Director, Arcutis Biotherapeutics, Inc.

Bought, 12 months
$0.0M
Sold, 12 months
$2.4M
Companies
1
Latest trade
Oct 15, 2026

Companies

Arcutis Biotherapeutics, Inc.Director −$2.6M

Trades

ARQT Sold 4,728 shares at $26.93 · planned $0.1M Oct 15 Form 4
ARQT Sold 4,730 shares at $24.18 · planned $0.1M Sep 15 Form 4
ARQT Sold 4,730 shares at $26.18 · planned $0.1M Aug 17 Form 4
ARQT Sold 4,730 shares at $26.91 · planned $0.1M Jul 15 Form 4
ARQT Sold 635 shares at $25.67 · planned $0.0M Jun 17 Form 4
ARQT Sold 4,096 shares at $24.41 · planned $0.1M Jun 15 Form 4
ARQT Sold 7,144 shares at $22.99 · planned $0.2M May 1 Form 4
ARQT Sold 10,000 shares at $23.88 · planned $0.2M Apr 1 Form 4
ARQT Sold 10,000 shares at $25.65 · planned $0.3M Mar 2 Form 4
ARQT Sold 10,000 shares at $25.05 · planned $0.3M Feb 2 Form 4
ARQT Sold 10,000 shares at $28.96 · planned $0.3M Jan 2 Form 4
ARQT Sold 10,000 shares at $30.21 · planned $0.3M Dec 1 Form 4
ARQT Sold 10,000 shares at $25.27 · planned $0.3M Nov 3 Form 4
ARQT Sold 10,000 shares at $18.92 · planned $0.2M Oct 1 Form 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

↑ ↓ to move · ↵ to open